BATS Exchange received approval from the U.S. Securities and Exchange Commission to implement its new Competitive Liquidity Provider (CLP) program for its exchange listings business.
The BATS CLP Program was designed for BATS’ new U.S. primary listings business as a rewards-based program, which is structured to incent market makers to make tighter quoted spreads with increased liquidity for each listing on BATS.
“As we grow our listings business, we’re creating new and unique ways to make the markets better for today’s issuer and enhance competition in the exchange listings business,” stated Joe Ratterman, Chairman and CEO of BATS Global Markets in today’s announcement. “Our Competitive Liquidity Provider program is designed to help improve market quality for issuers and we are excited to bring this innovative program to market.”
The CLP program particularly benefits small and mid-cap companies, according to parent BATS Global Markets, noting they are often challenged by a lack of liquidity in their stock, which can make attracting larger investors difficult. Through the BATS CLP program, market makers compete for a daily reward by posting competitive quotes in a stock or exchange traded product (ETP). CLPs are rewarded based on their continuous daily quoted size at the National Best Bid/Offer (NBBO) in the securities for which they are registered CLPs. Each liquidity provider must be a registered market maker on BATS and register and be approved by BATS to be a CLP for a listing. There is no limit to the number of CLPs that can be registered in each corporate listing. Additionally for ETPs, rather than designating a single liquidity provider, the CLP program encourages multiple liquidity providers to participate in the launch of an ETP public offering.
Ivy is Editor-at-Large for Advanced Trading and Wall Street & Technology. Ivy is responsible for writing in-depth feature articles, daily blogs and news articles with a focus on automated trading in the capital markets. As an industry expert, Ivy has reported on a myriad ... View Full Bio